Jefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Jefferies analyst Maury Raycroft initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Buy rating and announces Price Target of $29.
Jefferies analyst Maury Raycroft initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Buy rating and announces Price Target of $29.